FDA official logo
GSRS logoPFDA official logo

BRENIPATIDE

UNII:C3939LZT6J
Type:INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:BRENIPATIDE
GSRS Full Record:
C3939LZT6J
i

  • 2408921-49-1
  • BRENIPATIDE [USAN]
  • Brenipatide
  • D -tyrosyl-2-methylalanyl-L-α-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L -α-aspartyl-L-tyrosyl-L-seryl-L-isoleucyl-2-methyl-L-leucyl-L-leucyl-L-α-aspartyl-L -lysyl-N<sup>6</sup>-[(22S)-22,42-dicarboxy-10,19,24-trioxo-3,6,12,15-tetraoxa-9,18,23-triazadotetracontan-1-oyl]- L -lysyl-L-alanyl-L-glutaminyl-2-methylalanyl-L-α-glutamyl-L-phenylalanyl-L-isoleucyl- L-α-glutamyl-α-methyl-L-tyrosyl-L-leucyl-L-isoleucyl-L-alanylglycylglycyl-L-prolyl-L-seryl-L-serylglycyl-L-alanyl-L-prolyl- L-prolyl-L-prolyl-L-serinamide gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist
  • D-Tyrosyl-2-methylalanyl-L-α-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-α-aspartyl-L-tyrosyl-L-seryl-L-isoleucyl-2-methyl-L-leucyl-L-leucyl-L-α-aspartyl-L-lysyl-N6-[N-(19-carboxy-1-oxononadecyl) -L-γ-glutamyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-2-[2-(2-aminoethoxy)ethoxy]acetyl] -L-lysyl-L-alanyl-L-glutaminyl-2-methylalanyl-L-α-glutamyl-L-phenylalanyl-L-isoleucyl-L-α-glutamyl-α-methyl-L-tyrosyl-L-leucyl-L-isoleucyl-L-alanylglycylglycyl-L-prolyl-L-seryl-L-serylglycyl-L-alanyl-L-prolyl-L-prolyl-L-prolyl-L-serinamide
  • L-Serinamide, D-tyrosyl-2-methylalanyl-L-α-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-α-aspartyl-L-tyrosyl-L-seryl-L-isoleucyl-2-methyl-L-leucyl-L-leucyl-L-α-aspartyl-L-lysyl-N6-[N-(19-carboxy-1-oxononadecyl)-L-γ-glutamyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-2-[2-(2-aminoethoxy)ethoxy]acetyl]-L-lysyl-L-alanyl-L-glutaminyl-2-methylalanyl-L-α-glutamyl-L-phenylalanyl-L-isoleucyl-L-α-glutamyl-α-methyl-L-tyrosyl-L-leucyl-L-isoleucyl-L-alanylglycylglycyl-L-prolyl-L-seryl-L-serylglycyl-L-alanyl-L-prolyl-L-prolyl-L-prolyl-
  • LY-3537031
  • LY3537031
  • brenipatide [INN]




UNII - C3939LZT6J | UNII Search Service